Free Newsletters - Space - Defense - Environment - Energy - Solar - Nuclear
by Staff Writers
Houston (UPI) Apr 14, 2011
Drugs intended to treat minor illnesses of astronauts in space may need special handling to remain stable in the environment of space, NASA scientists say.
Researchers at the Johnson Space Center in Houston, writing in the AAPS Journal, suggest that some of the pharmaceuticals stored on space flights may have shorter shelf-life than they do on Earth.
They compared physical and chemical changes in 35 formulations in identical pharmaceutical kits stowed on the International Space Station and on Earth, and found that after 28 months of stowage in space medications from each flight kit had a lower active pharmaceutical content than the same pharmaceuticals kept on the ground.
"It is important to characterize space-specific degradation products and toxicity limits using ground-based analogue environments of space that include proton and heavy ion radiation, vibration and multiple gravity conditions," the researchers wrote.
"This information can facilitate research for the development of space-hardy pharmaceuticals and packaging technologies."
Space Medicine Technology and Systems
|The content herein, unless otherwise known to be public domain, are Copyright 1995-2014 - Space Media Network. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. Privacy Statement|